Cargando…

High VSX1 expression promotes the aggressiveness of clear cell renal cell carcinoma by transcriptionally regulating FKBP10

BACKGROUND: Clear cell renal cell carcinoma (ccRCC), the most common urological malignancy, has an unfavorable prognosis and an unknown mechanism of progression. Through survival analyses screening of The Cancer Genome Atlas (TCGA) dataset, we identified Visual system homeobox1 (VSX1) as a novel pot...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Wenliang, Li, Xin, Yang, Lei, Pan, Jun, Chen, Yi, Lu, Yanwen, Dong, Xiang, Li, Dongmei, Gan, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719260/
https://www.ncbi.nlm.nih.gov/pubmed/36463181
http://dx.doi.org/10.1186/s12967-022-03772-2
_version_ 1784843282405130240
author Ma, Wenliang
Li, Xin
Yang, Lei
Pan, Jun
Chen, Yi
Lu, Yanwen
Dong, Xiang
Li, Dongmei
Gan, Weidong
author_facet Ma, Wenliang
Li, Xin
Yang, Lei
Pan, Jun
Chen, Yi
Lu, Yanwen
Dong, Xiang
Li, Dongmei
Gan, Weidong
author_sort Ma, Wenliang
collection PubMed
description BACKGROUND: Clear cell renal cell carcinoma (ccRCC), the most common urological malignancy, has an unfavorable prognosis and an unknown mechanism of progression. Through survival analyses screening of The Cancer Genome Atlas (TCGA) dataset, we identified Visual system homeobox1 (VSX1) as a novel potential prognostic biomarker in ccRCC and subsequently investigated the oncogenic role of VSX1 in ccRCC. METHODS: The differential expression of VSX1 in human tumors and the clinical prognoses were analyzed in the TCGA dataset and Gene Expression Omnibus. Spearman’s correlation coefficient was determined for the correlation analysis of VSX1 expression and other genes of interest. The roles of VSX1 in cell proliferation, invasion, and migration of ccRCC cells were evaluated via the CCK-8 assay, colony formation assay, and Transwell assay, respectively. Further results were demonstrated by western blotting, immunohistochemistry, qRT-PCR, tumor sphere formation, flow cytometry, and the dual‑luciferase reporter assay. RESULTS: VSX1 mRNA upregulation was generally observed in multiple human malignancies from the TCGA database and was confirmed in ccRCC clinical specimens from our department. High VSX1 expression usually indicated that overall and disease-free survival were unfavorable for patients with ccRCC. In terms of mechanism, knockdown or overexpression of VSX1 affected ccRCC aggressiveness in vitro. The dual-luciferase reporter gene assay implied that VSX1 overexpression significantly increased the luciferase activity of TMEM44, FKBP10, and TRIB3, which indicated that VSX1 promoted ccRCC invasiveness via transcriptional regulation of these genes. The significantly enhanced growth in vitro that was induced by stable VSX1 overexpression was almost restored to normal by the knockdown of FKBP10. CONCLUSIONS: This study demonstrated that VSX1 was a novel prognostic biomarker in ccRCC and that high VSX1 expression promoted cell proliferation, invasion, and migration in ccRCC via transcriptional activation of downstream target genes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03772-2.
format Online
Article
Text
id pubmed-9719260
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97192602022-12-04 High VSX1 expression promotes the aggressiveness of clear cell renal cell carcinoma by transcriptionally regulating FKBP10 Ma, Wenliang Li, Xin Yang, Lei Pan, Jun Chen, Yi Lu, Yanwen Dong, Xiang Li, Dongmei Gan, Weidong J Transl Med Research BACKGROUND: Clear cell renal cell carcinoma (ccRCC), the most common urological malignancy, has an unfavorable prognosis and an unknown mechanism of progression. Through survival analyses screening of The Cancer Genome Atlas (TCGA) dataset, we identified Visual system homeobox1 (VSX1) as a novel potential prognostic biomarker in ccRCC and subsequently investigated the oncogenic role of VSX1 in ccRCC. METHODS: The differential expression of VSX1 in human tumors and the clinical prognoses were analyzed in the TCGA dataset and Gene Expression Omnibus. Spearman’s correlation coefficient was determined for the correlation analysis of VSX1 expression and other genes of interest. The roles of VSX1 in cell proliferation, invasion, and migration of ccRCC cells were evaluated via the CCK-8 assay, colony formation assay, and Transwell assay, respectively. Further results were demonstrated by western blotting, immunohistochemistry, qRT-PCR, tumor sphere formation, flow cytometry, and the dual‑luciferase reporter assay. RESULTS: VSX1 mRNA upregulation was generally observed in multiple human malignancies from the TCGA database and was confirmed in ccRCC clinical specimens from our department. High VSX1 expression usually indicated that overall and disease-free survival were unfavorable for patients with ccRCC. In terms of mechanism, knockdown or overexpression of VSX1 affected ccRCC aggressiveness in vitro. The dual-luciferase reporter gene assay implied that VSX1 overexpression significantly increased the luciferase activity of TMEM44, FKBP10, and TRIB3, which indicated that VSX1 promoted ccRCC invasiveness via transcriptional regulation of these genes. The significantly enhanced growth in vitro that was induced by stable VSX1 overexpression was almost restored to normal by the knockdown of FKBP10. CONCLUSIONS: This study demonstrated that VSX1 was a novel prognostic biomarker in ccRCC and that high VSX1 expression promoted cell proliferation, invasion, and migration in ccRCC via transcriptional activation of downstream target genes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03772-2. BioMed Central 2022-12-03 /pmc/articles/PMC9719260/ /pubmed/36463181 http://dx.doi.org/10.1186/s12967-022-03772-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ma, Wenliang
Li, Xin
Yang, Lei
Pan, Jun
Chen, Yi
Lu, Yanwen
Dong, Xiang
Li, Dongmei
Gan, Weidong
High VSX1 expression promotes the aggressiveness of clear cell renal cell carcinoma by transcriptionally regulating FKBP10
title High VSX1 expression promotes the aggressiveness of clear cell renal cell carcinoma by transcriptionally regulating FKBP10
title_full High VSX1 expression promotes the aggressiveness of clear cell renal cell carcinoma by transcriptionally regulating FKBP10
title_fullStr High VSX1 expression promotes the aggressiveness of clear cell renal cell carcinoma by transcriptionally regulating FKBP10
title_full_unstemmed High VSX1 expression promotes the aggressiveness of clear cell renal cell carcinoma by transcriptionally regulating FKBP10
title_short High VSX1 expression promotes the aggressiveness of clear cell renal cell carcinoma by transcriptionally regulating FKBP10
title_sort high vsx1 expression promotes the aggressiveness of clear cell renal cell carcinoma by transcriptionally regulating fkbp10
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719260/
https://www.ncbi.nlm.nih.gov/pubmed/36463181
http://dx.doi.org/10.1186/s12967-022-03772-2
work_keys_str_mv AT mawenliang highvsx1expressionpromotestheaggressivenessofclearcellrenalcellcarcinomabytranscriptionallyregulatingfkbp10
AT lixin highvsx1expressionpromotestheaggressivenessofclearcellrenalcellcarcinomabytranscriptionallyregulatingfkbp10
AT yanglei highvsx1expressionpromotestheaggressivenessofclearcellrenalcellcarcinomabytranscriptionallyregulatingfkbp10
AT panjun highvsx1expressionpromotestheaggressivenessofclearcellrenalcellcarcinomabytranscriptionallyregulatingfkbp10
AT chenyi highvsx1expressionpromotestheaggressivenessofclearcellrenalcellcarcinomabytranscriptionallyregulatingfkbp10
AT luyanwen highvsx1expressionpromotestheaggressivenessofclearcellrenalcellcarcinomabytranscriptionallyregulatingfkbp10
AT dongxiang highvsx1expressionpromotestheaggressivenessofclearcellrenalcellcarcinomabytranscriptionallyregulatingfkbp10
AT lidongmei highvsx1expressionpromotestheaggressivenessofclearcellrenalcellcarcinomabytranscriptionallyregulatingfkbp10
AT ganweidong highvsx1expressionpromotestheaggressivenessofclearcellrenalcellcarcinomabytranscriptionallyregulatingfkbp10